The Latest Cardiac and Vascular News
Northwell Health has joined the Cardiometabolic Center Alliance (CMCA) as a charter member, which was founded by Saint Luke’s Mid America Heart Institute in St. Louis, to provide innovative treatment approaches to patients with type 2 diabetes and cardiovascular disease. As a charter member, Northwell will further its ongoing research […]
Results presented at EuroPCR 2022 show notable reduction of blood pressure in patients on and off medications at six months PALO ALTO, Calif.–(BUSINESS WIRE)–ReCor Medical, Inc. (“ReCor”) and Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) a fully owned subsidiary of Otsuka Holdings Co., Ltd., today announced that Dr. Ajay […]
Medtronic adds to SPYRAL HTN Global Clinical Program with late breaking clinical data for SPYRAL HTN-ON MED and GSR-DEFINE DUBLIN and PARIS, May 17, 2022 /PRNewswire/ — Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced data showing the benefits of the Symplicity Blood Pressure Procedure with the Symplicity Spyral™ Renal Denervation […]
The heart failure program is a new model for cardiology practices in managing heart failure, starting with patients in Northeast Florida NEW YORK, May 17, 2022 /PRNewswire/ — Novocardia, a value-based cardiovascular disease care platform, has launched an innovative heart failure program that combines individualized health coaching and remote patient monitoring to improve […]
LITTLE ROCK, Ark., May 17, 2022 /PRNewswire/ — HealthTech Arkansas and MedAxiom have come together to create HeartX, a cardiovascular-focused healthcare accelerator, to facilitate guaranteed hospital pilot projects and clinical trials for accomplished, early-stage companies bringing new cardiovascular innovations to market. Applications for the 2022 HeartX cohort are now open, and companies […]
ROCKVILLE, Md. , May 17, 2022 /PRNewswire/ — A new position paper published today by the Heart Failure Society of America (HFSA) outlines disparities in healthcare that affect patients with heart failure, including race and ethnicity, socioeconomic factors, and social determinants of health. The statement also presents actions that can be taken to […]
AV-101 is being developed to address cellular hyperproliferation and resistance to apoptosis in the pulmonary vasculature, which are key features of the pathophysiology of PAH PAH is an area of high unmet need, and currently approved therapies are limited by acting primarily through vasodilation These Phase 1 results show that […]
FDA Plans to Convene Advisory Committee Meeting SOUTH SAN FRANCISCO, Calif., May 17, 2022 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the Company recently participated in a mid-cycle communication meeting with the U.S. Food & Drug Administration (FDA) and was informed that the Agency plans to convene an […]
LONDON, May 16, 2022 /PRNewswire/ — Tamer, the Middle-East’s leading healthcare distribution company, has agreed a 5-year deal to bring Huma’s market leading technology platform to power ‘hospitals at home’ with remote patient monitoring to the 34 million people living in the Kingdom of Saudi Arabia. The new health programme will begin with support for […]
PDUFA action date set for October 8, 2022 Company preparing for Q4 commercial launch, if approved BURLINGTON, Mass., May 16, 2022 (GLOBE NEWSWIRE) — scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient […]
